Technology News and Research

RSS

Calando Pharmaceuticals demonstrates first targeted siRNA-containing nanoparticle delivery to tumors

Arrowhead Research Corporation today announced that the clinical trial being conducted by majority-owned subsidiary, Calando Pharmaceuticals, Inc., has demonstrated systemic delivery of siRNA and the successful “silencing” of a widely recognized cancer gene via RNA interference (RNAi) in humans.

22 Mar 2010

iMDsoft's MetaVision suite of solutions to be distributed by Dominion in Spain

iMDsoft®, a global leader in hospital-wide clinical information systems, and Dominion, a leading provider of technology solutions in Spain and Latin America, have announced an agreement whereby Dominion will distribute iMDsoft's MetaVision® suite of solutions in Spain.

22 Mar 2010

Aston University scientists receive grants to develop new forms of drug delivery

Before you swallow a tablet, or put it into a glass of water to dissolve, do you ever stop and think about how it actually works in your body and how quickly and effectively it can deliver the drug to where it is needed?

22 Mar 2010

Lab on a Chip for research on oxygen impact on brain cells

A mini-laboratory that makes it possible, among other things, to study how brain cells in stroke patients are affected by lack of oxygen is being developed by a research team at Luleå University of Technology in Sweden. Lab on a Chip is what the scientists are calling their mini-lab, which is expected to facilitate studies of all sorts of biological cells and how they are affected by different medicines, chemical substances, etc.

22 Mar 2010

ILSI Biomed Israel 2010 international conference to be held in Tel Aviv

Set against the backdrop of the global market recovery and the recent proliferation of the life sciences field, this June’s ILSI Biomed Israel 2010 international conference will be attended by the most prominent figures in the biotechnology, pharma and medical device sectors.

22 Mar 2010

Tricking TB into suicidal self-poisoning

Scientists have identified a new class of drug target that tricks tuberculosis bacteria into suicidal self-poisoning. New therapies are urgently required to control the tuberculosis pandemic. Even in the UK cases are on the rise.

22 Mar 2010

Team Consulting to provide Oval Medical Technologies new funds in exchange for equity

Leading medical technology firm Team Consulting has joined the consortium of investors that is providing seed funding to Oval Medical Technologies, a developer of proprietary medical pre-filled syringes and autoinjectors.

22 Mar 2010

Nanotechnology weapons for cancer

US Researchers have come up with new nanoparticle robots that are essentially a tiny army that can travel in the blood till they reach the cancers and then tweak some important cancer causing genes that can cure the cancer.

22 Mar 2010

Caltech-led trial demonstrates feasibility of nanoparticles and RNAi-based therapeutics for treating cancer

A California Institute of Technology -led team of researchers and clinicians has published the first proof that a targeted nanoparticle-used as an experimental therapeutic and injected directly into a patient's bloodstream-can traffic into tumors, deliver double-stranded small interfering RNAs (siRNAs), and turn off an important cancer gene using a mechanism known as RNA interference (RNAi).

22 Mar 2010

Study: Older adults with chronic illness often struggle to manage several prescribed drugs at a time

People with chronic illness often struggle to manage several prescribed drugs at a time. It's overwhelming when the vials, bottles and inhalers bulge from your medicine cabinet and you're confused about which drug is which, or when to take what.

20 Mar 2010

Portable ultrasound device to treat chronic joint pain from arthritis

In recent years, doctors have used ultrasound to effective treat joint pain from arthritis and other ailments without the use of drugs. The drawback to these treatments, however, is that they can only be administered in a doctor's office or clinic, since the ultrasound devices currently used are bulky and expensive.

20 Mar 2010

Dartmouth-Hitchcock Medical Center awarded ECRI Institute Health Devices Achievement Award

Masimo, the inventor of Pulse CO-Oximetry™ and Measure-Through Motion and Low Perfusion pulse oximetry, is pleased to report that Dartmouth-Hitchcock Medical Center (Lebanon, New Hampshire) has received the 4th Annual ECRI Institute Health Devices Achievement Award yesterday for an innovative patient monitoring project that uses its Masimo SET pulse oximetry and Masimo Patient SafetyNet remote monitoring and clinician notification system.

20 Mar 2010

EUREKA project develops unique range of antibodies

EUREKA project E! 3424 RECAN has developed a range of unique and highly specific monoclonal and polyclonal antibodies - the proteins produced in the blood which counteract bacteria, viruses or cancerous cells.

20 Mar 2010

House Democrats prepare for Sunday vote on health reconciliation bill

The Associated Press: "In seeking enough votes to overhaul the nation's health care system, President Barack Obama is telling nervous Democratic lawmakers that their political fates are linked to the bill's passage, discouraging the notion that they can save themselves by opposing it, House members say." White House Press Secretary Robert Gibbs "who said the president has spoken with more than three dozen Democratic lawmakers since Monday, repeatedly sidestepped questions of whether Obama has told them his presidency's fate depends on the legislation's passage" (Babington, 3/19).

20 Mar 2010

ITDS can be effective for screening fever during H1N1 influenza pandemic: UNMC researchers

Researchers at the University of Nebraska Medical Center found an Infrared Thermal Detection System to be a fast and effective fever screening tool in clinical settings during the H1N1 influenza pandemic. The ITDS detected fever in patients through split-second, non-contact skin temperature measurements.

20 Mar 2010

FDA panel favors approval with conditions of Medtronic's Revo MRI SureScan pacing system

Medtronic, Inc.today announced that the U.S. Food and Drug Administration (FDA) Circulatory System Devices Panel of the Medical Devices Advisory Committee has voted unanimously in favor of approval with conditions of the Revo MRI™ SureScan™ pacing system designed as MR Conditional, or safe for use in Magnetic Resonance Imaging (MRI) systems under specified conditions.

20 Mar 2010

Mental activity during meditation is wakeful and relaxed, says study

Forget about crystals, candles, Eastern philosophy, and about sitting and breathing in awkward ways. Meditation research explores how the brain works when we refrain from concentration, rumination and intentional thinking.

20 Mar 2010

Recent releases in Global Health

A Lancet study performed a systematic review of HIV prevention and treatment services targeting injecting drug users (IDUs) globally based on the availability of "core interventions for IDUs: needle and syringe programmes (NSPs), opioid substitution therapy (OST) and other drug treatment, HIV testing and counselling, antiretroviral therapy (ART), and condom programmes." The authors conclude, "although the number of countries with core HIV prevention services is growing … worldwide, there are few countries in which the level of intervention coverage is sufficient to prevent HIV transmission" (Mathers et al., 3/20).

20 Mar 2010

Bovie Medical receives FDA marketing clearance for BOSS bipolar sintered steel coagulation device

Bovie Medical Corporation, a manufacturer and marketer of electrosurgical products, today announced the Company received clearance from the Food and Drug Administration (FDA) to market its proprietary BOSS™ bipolar sintered steel coagulation device. The BOSS™ is the latest device based on Bovie’s saline enhanced sintered steel technology.

19 Mar 2010

Comprehensive community-based solution to help achieve 'meaningful use'

Navigating the Challenges of Meaningful Use to Identify Benefits, March 31, 2010, 2 p.m. CT, a Webinar hosted by Informatics Corporation of America, will explore how to practically implement a community-wide solution that assists its healthcare participants to achieve the proposed American Recovery and Reinvestment Act’s criteria for meaningful use and bridge gaps in the adoption of electronic health records by its provider community.

19 Mar 2010

Technology News and Research

Calando Pharmaceuticals demonstrates first targeted siRNA-containing nanoparticle delivery to tumors

iMDsoft's MetaVision suite of solutions to be distributed by Dominion in Spain

Aston University scientists receive grants to develop new forms of drug delivery

Lab on a Chip for research on oxygen impact on brain cells

ILSI Biomed Israel 2010 international conference to be held in Tel Aviv

Tricking TB into suicidal self-poisoning

Team Consulting to provide Oval Medical Technologies new funds in exchange for equity

Nanotechnology weapons for cancer

Caltech-led trial demonstrates feasibility of nanoparticles and RNAi-based therapeutics for treating cancer

Study: Older adults with chronic illness often struggle to manage several prescribed drugs at a time

Portable ultrasound device to treat chronic joint pain from arthritis

Dartmouth-Hitchcock Medical Center awarded ECRI Institute Health Devices Achievement Award

EUREKA project develops unique range of antibodies

House Democrats prepare for Sunday vote on health reconciliation bill

ITDS can be effective for screening fever during H1N1 influenza pandemic: UNMC researchers

FDA panel favors approval with conditions of Medtronic's Revo MRI SureScan pacing system

Mental activity during meditation is wakeful and relaxed, says study

Recent releases in Global Health

Bovie Medical receives FDA marketing clearance for BOSS bipolar sintered steel coagulation device

Comprehensive community-based solution to help achieve 'meaningful use'

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

Latest News